Testosterone Enanthate Cost in South Dakota 2026

What Does Testosterone Enanthate Actually Cost in South Dakota?

The cash-pay price for testosterone enanthate at South Dakota retail pharmacies averages about $70 per month in 2026. The manufacturer list price sits closer to $120 per month. With discount cards such as GoodRx, some patients report paying $40 to $60 per month at chains including Walmart, Walgreens, and Sanford pharmacies in Sioux Falls and Rapid City.

Retail vs. Compounded vs. List Price

Three price tiers exist for South Dakota patients. First, brand or generic retail versions sold by national chains come in at roughly $70/month cash. Second, the manufacturer's own list price of approximately $120/month is what insurers are billed before rebates. Third, 503A compounding pharmacies licensed in South Dakota may prepare testosterone enanthate for about $80/month, which can include a customized concentration or added excipients not available commercially.

Testosterone enanthate has been FDA-approved since 1954 for male hypogonadism and delayed puberty, with the current prescribing label available at the FDA's Drugs@FDA database. [1] The clinical rationale for testosterone replacement is well-supported: the T-Trials (N=788), published in the New England Journal of Medicine in 2016, showed that testosterone treatment in men 65 and older with low levels produced significant improvements in sexual function, physical capacity, and bone density over 12 months compared with placebo. [2]

Why Prices Vary Across South Dakota

Pharmacy acquisition costs differ by region. Rural pharmacies in towns like Aberdeen or Pierre may charge slightly more than high-volume Sioux Falls chains due to lower purchasing power. Generic testosterone enanthate from manufacturers such as Pfizer (Depo-Testosterone is cypionate, not enanthate, but the market dynamics overlap) and Hikma competes on price, keeping generic costs lower than many specialty hormones. [3]

The American Urological Association's 2018 guideline on testosterone deficiency notes that testosterone therapy is appropriate when both symptoms and a confirmed low serum testosterone level are present, which means insurers and Medicaid programs expect documented lab values before considering any coverage. [4]

South Dakota Medicaid Coverage for Testosterone Enanthate

South Dakota Medicaid does not cover testosterone enanthate for male hypogonadism under standard formulary rules in 2026. Patients enrolled in Medicaid who are diagnosed with hypogonadism will generally need to pay out of pocket or pursue prior authorization, which has a low approval rate for this indication under current state policy.

Who Might Still Qualify

Coverage may be available in narrow circumstances. Patients with a documented pituitary disorder, Klinefelter syndrome (47,XXY), or bilateral orchiectomy may have a stronger medical necessity argument. The Endocrine Society's 2018 Clinical Practice Guideline on male hypogonadism states: "We recommend making the diagnosis of androgen deficiency only in men with consistent symptoms and signs and unequivocally low serum testosterone concentrations." [5] Presenting that guideline language alongside lab values and an ICD-10 code of E29.1 (testicular hypofunction) may support a prior authorization appeal.

Medicaid Managed Care Plans in South Dakota

South Dakota Medicaid contracts with a small number of managed care organizations. Each MCO maintains its own preferred drug list. Patients should request the specific formulary exclusion letter in writing before appealing, because the appeal window is typically 30 to 60 days from the denial date. The CMS guidance on Medicaid formulary exceptions applies federally, but South Dakota has state-level discretion on which drugs are included for non-mandatory covered populations. [6]

Is Compounded Testosterone Enanthate Legal in South Dakota?

Yes. Licensed 503A compounding pharmacies operating in South Dakota may legally prepare testosterone enanthate for individual patients when a valid prescription from a licensed prescriber is present. Section 503A of the Federal Food, Drug, and Cosmetic Act governs these pharmacies, and the FDA's guidance on 503A compounders specifies the conditions under which compounding is permitted. [7]

503A vs. 503B Compounders

A 503A pharmacy compounds for individual patients on a prescription-by-prescription basis. A 503B outsourcing facility produces larger batches and sells to providers without patient-specific prescriptions, but testosterone enanthate is not on the FDA's current 503B bulk drug substance list, meaning 503B outsourcing facilities may not legally compound it. [8] Patients ordering from out-of-state 503B operations without a patient-specific prescription are in a legally ambiguous position.

What to Look for in a South Dakota Compounding Pharmacy

Patients should confirm that their compounding pharmacy holds a current South Dakota Board of Pharmacy license and, ideally, PCAB (Pharmacy Compounding Accreditation Board) accreditation. The United States Pharmacopeia's USP 795 and USP 797 standards govern non-sterile and sterile compounding quality respectively, and testosterone enanthate injections fall under sterile compounding rules. [9] A pharmacy meeting USP 797 standards uses ISO-classified cleanrooms and batch testing for potency and sterility.

The compounded price of approximately $80/month in South Dakota reflects the cost of those quality controls plus the pharmacist's formulation time. It is not always cheaper than generic retail, so patients should compare quotes before committing.

Testosterone Enanthate Insurance Coverage in South Dakota

Private insurance coverage for testosterone enanthate in South Dakota depends heavily on the plan type, the prescriber's diagnosis code, and whether prior authorization is obtained. Large employer self-insured plans governed by ERISA often follow national pharmacy benefit manager (PBM) formularies from CVS Caremark, Express Scripts, or OptumRx.

Commercial Plan Tiers

Most commercial formularies place generic testosterone enanthate on Tier 2 or Tier 3. A Tier 2 placement typically means a $30 to $60 copay per 30-day supply. Tier 3 can push that to $80 to $120. Patients on high-deductible health plans pay the full negotiated price until the deductible is met, which could mean $90 to $110 per fill at the beginning of the plan year.

The negotiated (post-rebate) price that PBMs pay is often 40 to 60% below list price, per an analysis of Medicare Part D data published in JAMA in 2019. [10] That discount rarely passes fully to the patient under commercial plans, but it does reduce what the insurer ultimately spends.

Prior Authorization Requirements

Most commercial plans in South Dakota require prior authorization for testosterone therapy. Standard PA criteria align closely with the Endocrine Society's guideline threshold of two morning serum testosterone measurements below the laboratory's lower reference limit (typically <300 ng/dL on most assay platforms) plus documented symptoms. [5] A prescriber who submits both serum levels and a completed AUA or Endocrine Society symptom checklist with the PA request generally sees faster approvals.

ACA Marketplace Plans in South Dakota

South Dakota ACA Marketplace plans vary by carrier. Sanford Health Plan and Wellmark Blue Cross Blue Shield both operate in the state. Neither publicly commits to covering testosterone enanthate without prior authorization, and their 2026 formularies should be reviewed at Healthcare.gov's plan comparison tool before enrollment. The FDA's Orange Book lists generic testosterone enanthate as therapeutically equivalent, which typically makes it formulary-eligible, but listing does not guarantee coverage. [1]

Telehealth Prescribing of Testosterone Enanthate in South Dakota

South Dakota permits telehealth prescribing of controlled substances with important federal constraints. The DEA's telemedicine rules, updated after the COVID-19 public health emergency, require that a prescriber either complete an in-person evaluation at least once before prescribing a Schedule III controlled substance (testosterone enanthate is Schedule III) via telemedicine, or use a DEA-registered telemedicine platform that meets the Ryan Haight Online Pharmacy Consumer Protection Act requirements. [11]

What This Means Practically

A South Dakota patient can initiate testosterone enanthate therapy through a telehealth platform such as HealthRX if they have completed an in-person physical exam and lab work with any licensed provider, or if the telehealth platform has a qualifying in-person exam option in the state. Lab work (total testosterone, LH, FSH, hematocrit, and PSA for men over 40) must be reviewed before the prescription is sent. [5]

The T-Trials investigators noted that baseline screening and ongoing monitoring are essential to safe testosterone therapy, specifically citing hematocrit elevation as the most common adverse effect requiring dose adjustment. [2] Hematocrit rising above 54% is a standard threshold for pausing therapy, per the Endocrine Society guideline. [5]

Shipping to South Dakota

Once prescribed, testosterone enanthate can be dispensed by a DEA-registered pharmacy in South Dakota or shipped from an out-of-state retail pharmacy or compounding pharmacy licensed to dispense into the state. South Dakota does not restrict interstate pharmacy shipment beyond standard federal rules, meaning patients in rural areas (the majority of the state's land area) can receive medication by mail. [12]

Savings Programs and Discount Strategies for South Dakota Patients

Several programs reduce the effective out-of-pocket cost for South Dakota patients without insurance coverage.

GoodRx and Similar Discount Cards

GoodRx, RxSaver, and Blink Health function as PBM-negotiated discount programs. At South Dakota pharmacies, GoodRx prices for generic testosterone enanthate 200 mg/mL (10 mL vial) range from roughly $45 to $65 per fill depending on the dispensing pharmacy. These cards cannot be combined with insurance for the same claim, so patients with high-deductible plans in early-year deductible territory often save money using a discount card instead of their insurance.

Manufacturer Patient Assistance Programs

AbbVie's AndroGel has a patient assistance program, but testosterone enanthate (generic) does not have a single manufacturer PAP since multiple generic manufacturers supply it. Patients who need brand-name products such as Xyosted (testosterone enanthate subcutaneous, by Antares Pharma) may access Antares's savings card, which can reduce cost to $0 for eligible commercially insured patients. The Xyosted prescribing information is available through the FDA's Drugs@FDA portal. [13]

State Pharmaceutical Assistance

South Dakota does not operate a state pharmaceutical assistance program (SPAP) for working-age adults with testosterone deficiency. The South Dakota Department of Social Services manages the state's Medicaid program; no supplemental drug subsidy exists outside of federal Low Income Subsidy (LIS) for Medicare Part D enrollees. Medicare Part D covers testosterone enanthate under some plans' formularies for men with documented hypogonadism, and the CMS formulary finder tool at Medicare.gov can identify which Part D plans in South Dakota include it. [6]

Dosing, Administration, and Monitoring Costs to Factor In

The sticker price of testosterone enanthate is only part of the monthly cost. Ongoing lab monitoring and injection supplies add to the total.

Standard Dosing in South Dakota Clinical Practice

The FDA-approved dose range for testosterone enanthate in male hypogonadism is 50 to 400 mg intramuscularly every 2 to 4 weeks. [1] Many South Dakota prescribers, guided by the Endocrine Society's preference for more stable serum levels, use 100 mg once weekly rather than larger doses every 2 to 4 weeks. Weekly dosing reduces peak-to-trough fluctuation and lowers the hematocrit spike seen with higher infrequent dosing. [5]

A 10 mL multi-dose vial at 200 mg/mL contains 2,000 mg total. At 100 mg per week, that vial lasts 20 weeks, meaning one vial every 4 to 5 months. At retail prices of $45 to $70 per vial, the medication cost alone is approximately $10 to $15 per week.

Injection Supplies

Syringes and needles are inexpensive. A 3 mL syringe with a 21-gauge 1.5-inch needle, appropriate for intramuscular injection, costs roughly $0.30 to $0.50 per unit at retail. At once-weekly injections, annual supply cost is under $30. Patients performing self-injection at home in South Dakota do not need a prescription for syringes under current state law. [12]

Lab Monitoring Schedule

The Endocrine Society recommends checking testosterone levels, hematocrit, and PSA at 3 to 6 months after starting therapy, then annually once stable. [5] A comprehensive metabolic panel, CBC, and hormone panel at a South Dakota commercial lab (Sanford, Avera, Quest, LabCorp) costs $80 to $200 without insurance. With insurance, patient cost may be $20 to $50. Budget roughly $150 to $400 per year for monitoring labs, depending on frequency and insurance status.

The HealthRX clinical team uses a standardized intake framework for South Dakota TRT candidates that combines two morning testosterone draws (before 10 a.m., fasting), an LH/FSH panel to classify primary vs. Secondary hypogonadism, a baseline PSA for men over 40, a hematocrit, and a brief symptom score using the Aging Males' Symptoms (AMS) scale. This framework reduces PA denial rates by ensuring the prescriber submits all insurer-required data in the first submission rather than after a denial and appeal cycle.

Total Monthly Cost Estimate for a South Dakota Patient in 2026

Pulling all the numbers together, a South Dakota man paying cash for testosterone enanthate at once-weekly 100 mg dosing can expect:

• Medication: $10 to $15 per week ($43 to $65/month from one vial lasting 4 to 5 months)
• Syringes and needles: under $3/month
• Telehealth visit (if applicable): $50 to $150 for initial visit, often $0 to $50 for follow-ups
• Lab monitoring (annualized monthly): $12 to $33/month

Total estimated monthly cost (cash-pay, no insurance): approximately $70 to $115 per month all-in. Patients with commercial insurance covering TRT labs and copays in the $30 to $60 range may land at $60 to $90/month. Patients using discount cards and home self-injection on the lower end of this range may reach $55 to $75/month.

The Endocrine Society guideline specifically states: "We suggest that clinicians aim to achieve serum testosterone levels in the mid-normal range." [5] Achieving that target requires dose titration, which is best managed through a provider experienced in TRT rather than a one-size protocol, regardless of whether care is delivered in person or via telehealth.